These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas. Somay E, Yilmaz B, Topkan E, Ozdemir BS, Ozturk D, Besen AA, Mertsoylu H, Selek U. Int J Biol Markers; 2024 Mar; 39(1):80-88. PubMed ID: 38192114 [Abstract] [Full Text] [Related]
3. Low hemoglobin levels predict increased radiation-induced trismus rates in nasopharyngeal cancer. Somay E, Yilmaz B, Topkan E, Pehlivan B, Selek U. Oral Dis; 2024 Apr; 30(3):1052-1060. PubMed ID: 37154238 [Abstract] [Full Text] [Related]
4. The predictive usefulness of the novel "combined hemoglobin-to-platelet ratio and maximum mouth opening index" on prevalence of radiation induced trismus in patients with nasopharyngeal cancer. Somay E, Yilmaz B, Topkan E, Kucuk A, Pehlivan B, Selek U. Head Neck; 2023 Jul; 45(7):1823-1831. PubMed ID: 37173823 [Abstract] [Full Text] [Related]
6. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy. Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U. BMC Oral Health; 2023 Apr 20; 23(1):231. PubMed ID: 37081475 [Abstract] [Full Text] [Related]
7. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients. Topkan E, Somay E, Yilmaz B, Pehlivan B, Selek U. BMC Cancer; 2023 Jul 12; 23(1):651. PubMed ID: 37438683 [Abstract] [Full Text] [Related]
8. Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients. Somay E, Topkan E, Bascil S, Kılıc Durankuş N, Senyürek Ş, Ozturk D, Pehlivan B, Selek U. Biomol Biomed; 2024 Oct 17; 24(6):1703-1710. PubMed ID: 38860864 [Abstract] [Full Text] [Related]
15. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis. Liu H, Chen QY, Guo L, Tang LQ, Mo HY, Zhong ZL, Huang PY, Luo DH, Sun R, Guo X, Cao KJ, Hong MH, Mai HQ. Radiat Oncol; 2013 Mar 22; 8():70. PubMed ID: 23521779 [Abstract] [Full Text] [Related]
16. Topkan's CARWL Index Efficiently Predicts the Radiation-Induced Tooth Loss Rates in Radically Treated Locally Advanced Nasopharyngeal Cancer Patients. Somay E, Topkan E, Bascil S, Ozturk D, Senyurek S, Durankus NK, Selek U. Technol Cancer Res Treat; 2024 Mar 22; 23():15330338241292234. PubMed ID: 39420731 [Abstract] [Full Text] [Related]
17. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma. Wu L, Chung YL. Int J Radiat Oncol Biol Phys; 2019 May 01; 104(1):165-176. PubMed ID: 30654091 [Abstract] [Full Text] [Related]